Fmoc-alpha-Me-L-Phe(2-F)-OH

Fmoc-alpha-Me-L-Phe(2-F)-OH is an Fmoc-protected, L-configured amino acid derivative featuring an alpha-methylated backbone and a phenylalanine side chain bearing a fluorine substituent at the 2-position (ortho-fluoro). The molecule contains an N-(9H-fluoren-9-ylmethoxycarbonyl) protecting group that supports standard solid-phase peptide synthesis, while the carboxylic acid enables controlled peptide coupling and C-terminal incorporation. The stereogenic alpha carbon from the L-configuration, combined with the alpha-methyl substitution, imposes defined conformational bias that can influence dipeptide and longer peptide geometry during synthesis and downstream structure-activity relationship studies. The ortho-fluorine substituent provides a chemically stable handle for electronic and steric modulation, enabling fluorinated peptidomimetic design and analytical differentiation of peptide analogs.

1. Peptide Synthesis

Fmoc-alpha-Me-L-Phe(2-F)-OH is used as an Fmoc-protected amino acid building block for stepwise peptide assembly in research and manufacturing settings. The Fmoc carbamate protects the amino nitrogen during chain elongation, while the free carboxylic acid participates in peptide coupling to form amide bonds with incoming activated amino acid derivatives. The alpha-methylated L-configuration supports stereochemically defined incorporation, and the 2-fluoro phenyl side chain can be retained through coupling and deprotection conditions typical of protected amino acid chemistry. Resulting fluorinated peptides and peptide fragments can be generated for library synthesis, sequence optimization, and method development in peptide construction workflows.

2. Peptidomimetics And SAR

Fmoc-alpha-Me-L-Phe(2-F)-OH is applied in peptidomimetic construction and structure-activity relationship studies where fluorinated aromatic residues and alpha-methyl stereocenters are used to tune binding-site interactions. The ortho-fluoro substituent on the phenyl ring can modulate local dipole effects and steric profile relative to unsubstituted phenylalanine analogs, while the alpha-methyl group can bias backbone conformations and influence amide orientation. The Fmoc-protected amino acid format enables straightforward incorporation into peptide-like scaffolds, supporting systematic SAR campaigns that compare closely related fluorinated and non-fluorinated variants. Downstream derivatives such as fluorinated peptide analogs, constrained oligomers, and SAR-focused fragment sequences can be prepared for iterative medicinal chemistry exploration.

3. Chiral Amino Acid Intermediate

Fmoc-alpha-Me-L-Phe(2-F)-OH functions as a chiral amino acid intermediate for stereodefined synthesis of fluorinated, alpha-methylated amino acid derivatives. The L-configuration at the alpha carbon and the alpha-methyl substitution provide a defined stereochemical template for downstream transformations that retain or further elaborate the stereocenter. The Fmoc protecting group supports controlled N-functionalization strategies, including deprotection to reveal the amino group for subsequent derivatization or coupling into alternative peptide formats. The ortho-fluoro aromatic side chain can serve as a stable motif for generating additional chiral building blocks, analytical standards, and targeted fluorinated intermediates for fine chemical synthesis.

4. Side-Chain Functionalization

Fmoc-alpha-Me-L-Phe(2-F)-OH is suitable for side-chain functionalization strategies in synthetic organic chemistry and chemical biology research where fluorinated aromatic residues act as both structural elements and analytical tags. The 2-fluoro phenyl group can participate in selective transformations or remain intact to preserve electronic characteristics during scaffold elaboration, enabling controlled generation of fluorinated analog series. The carboxylic acid allows conversion into activated derivatives for further coupling chemistry, while the Fmoc-protected amine supports orthogonal protection logic when building multi-functional molecules. Resulting products may include fluorinated peptide fragments, modified aromatic side-chain variants, and chemically defined intermediates for studying structure-function relationships in amino acid-based systems.

5. Analytical Research Standards

Fmoc-alpha-Me-L-Phe(2-F)-OH is used to prepare analytical standards and reference materials for quantification and characterization of fluorinated peptides and peptide fragments. The defined stereochemistry and the presence of a single ortho-fluorine substituent create a distinct spectral signature that can support LC-MS/MS method development, retention-time mapping, and fragment ion assignment for amino acid and peptide analytics. The Fmoc-protected precursor format enables consistent incorporation into peptides used as calibrants or internal references, improving comparability across synthesis batches and analytical runs. Downstream peptide standards derived from this amino acid can support routine analytical research, impurity profiling, and structural verification in peptide chemistry workflows.

6. Pharmaceutical Manufacturing Intermediates

Fmoc-alpha-Me-L-Phe(2-F)-OH is applicable to pharmaceutical manufacturing and process chemistry contexts where protected amino acid intermediates are required for scalable peptide production. The Fmoc group provides a manufacturing-compatible protection strategy for N-terminal handling, while the free carboxylic acid enables reliable peptide coupling under standard protected amino acid synthesis conditions. The alpha-methyl L stereocenter and the ortho-fluoro aromatic side chain support consistent incorporation into defined peptide sequences, aiding process repeatability for fluorinated peptide intermediate generation. Resulting peptide products and intermediate fragments can be used in downstream manufacturing steps, including purification development, impurity control studies, and controlled synthesis of fluorinated peptide materials for applied product development.

1. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

2. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

3. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

4. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die

5. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes